the results are summarized of 13 published investigations of the beta-blocker 5- ( 3-tert-butylamino-2-hydroxy-propoxy ) -3 , 4-dihydro-2 ( 1h ) -quinolinone hydrochloride ( carteolol hydrochloride , endak , endak mite ) with a total of 378 patients suffering from cardiac rhythm irregularities ( tachycardias , extrasystoles ( es ) , arrhythmias ) .
C0340464
extrasystoles
C0003811
arrhythmias